Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 1043 | 1257 | 1000 | 1418 | 1904 |
Fund Return | 4.26% | 4.26% | 25.75% | 0.01% | 7.23% | 6.65% |
Place in category | 86 | 86 | 35 | 57 | 39 | 29 |
% in Category | 32 | 32 | 15 | 31 | 22 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PIMegatrend Selection I USD | 12.06B | 6.56 | 1.38 | 7.67 | ||
PIMegatrend Selection P dy USD | 12.06B | 6.32 | 0.47 | 6.76 | ||
PIMegatrend Selection R USD | 12.06B | 6.08 | -0.43 | 5.80 | ||
Pictet Global Megatrend Selection P | 12.06B | 6.32 | 0.47 | 6.76 | ||
PIMegatrend Selection Z USD | 12.06B | 4.81 | 2.05 | 8.29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Franklin Biotech Discovery Nacc | 105.94M | 4.88 | -4.60 | 3.64 | ||
Pictet Biotech PUSD | 1.48B | -18.50 | 5.47 | 7.18 | ||
Pictet Biotech R USD | 1.48B | -18.92 | 4.74 | 6.44 | ||
Equities L Biotechnology Class I US | 1.45B | 2.72 | 2.18 | 7.26 | ||
Equities L Biotechnology Class R US | 1.45B | 2.99 | 2.98 | 7.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Moderna | US60770K1079 | 4.98 | 111.62 | +3.38% | |
argenx ADR | US04016X1019 | 4.25 | 375.29 | +0.67% | |
Viking Therapeutics Inc | US92686J1060 | 3.94 | 75.420 | +1.49% | |
Biomarin Pharma | US09061G1013 | 3.86 | 82.13 | +1.51% | |
Blueprint Medicines Corp | US09627Y1091 | 3.82 | 93.10 | +0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review